Mab

May 20, 2020

I-Mab Expands Global Presence with New Hong Kong Office

Jan 02, 2020

Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief Financial Officer

Sep 12, 2019

I-Mab Biopharma Expands Global Team, Appoints Neil K. Warma As General Manager of I-Mab U.S.

Sep 04, 2019

Monoclonal Antibody Therapeutics to Drive the Biotherapeutics Market

Jul 10, 2019

MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China

Jan 22, 2019

I-Mab Biopharma Receives U.S. FDA IND Clearance for Proprietary CD73 Antibody TJD5

Nov 15, 2018

MorphoSys and I-Mab Sign Strategic Partnering Agreement for MorphoSys's Novel Immuno-Oncology Agent MOR210

Sep 24, 2018

Aridis Pharmaceuticals Strengthens Intellectual Property Portfolio With Additional Broad Patent Coverage For Multiple Product Candidates

Jun 29, 2018

I-Mab Successfully Raised USD 220 Million in Series C Funding

Dec 06, 2017

Novasep Invests EUR17 M in "mAbulous", its Dedicated cGMP Monoclonal Antibody (mAb) Production Facility